Sale of 150 shares of CyberArk (Entire Position); Purchase of 200 shares of Pagaya; Purchase of 200 shares of Rubrik; Purchase of 250 shares of Samsara; Purchase of 200 shares of Dynatrace; Purchase of 200 shares of Braze; Purchase of 50 shares of Atlassian; Purchase of 20 shares of Monday We have made some changes…
High growth equities were under some pressure in trading Thursday morning. Overall, the high growth portfolio has fallen about 3%. There is still tariff angst as the president has sent aggressive letters to some trade partners such as Brazil threatening punitive tariffs because of political issues. Further, the QQQs and other indices made all-time highs…
We made one opportunistic purchase this morning in the high growth portfolio, acquiring 400 shares of Braze and raising our position to 1100 shares. We bought the shares at $25.51 and this cost $10,210. That has brought our margin balance to $377,510. None of our other orders have been executed. If any go off, I…
I had indicated that I would constrain the margin balance to $350k in the high growth portfolio. I am mindful of the current environment with concerns about wars, tariffs and Fed policies. Economic data is mixed at best with both retail sales and housing starts showing negative trends. I get all that. But there were…
Summary SentinelOne shares are recommended as a strong buy despite recent market challenges and tariff concerns, due to their strong operational performance and promising outlook. The company’s Q4 results exceeded expectations with significant new customer acquisitions, strong ARR growth, and improved competitive positioning, highlighting effective sales execution. SentinelOne’s shift from end-point security to a comprehensive…
We sold our entire position in Braze shares this morning on its opening spike at $42.39. The numbers that Braze reported were strong-the guidance was really meh. We are not surprised that the guidance was meh-the environment for selling marketing software is very tough and recent news suggests it is getting tougher. The disposition of…
We have made the following changes in the high growth portfolio earlier this morning. CompanySharesPriceB/STotalOld Position New PositionWeightSprount Social1,500$66.69S$40,0251,50000%Datadog120$117.01S$14,02512000%Braze800$37.49B$30,00008003.5%Xometry300$27.69B$8,3151,2001,5003.4%Unity400$26.59B$10,6451,3001,7003.7%Procore50$79.49B$3,9805506003.9% Sprout Social reported yet another disappointing quarter with revenue growth forecasted at 10% for the full year. The company continues to report growth in bookings in the mid-high 20% range but somehow the bookings never translate into revenue…
We made a couple of changes in the high growth portfolio today. We sold our position in Braze (580 shares) at $43.99. Braze has rallied considerably since we bought the position in late October. While Braze is a leading vendor in the customer engagement space, its valuation is no longer quite the relative bargain it was when…
Axon’s run: What should readers do now? It has been little more than a year since I first recommended Axon (AXON) shares. So far in 2024, the shares are up 68% and they have consistently been making new all-time highs. The quintessential pattern of a momentum growth stock. Much of the share price increase has come since the latest earnings…
As foreshadowed in the weekly commentary I have made some portfolio changes. The rationale for these changes was in the weekly commentary. That said, if anyone has questions about why I have made these changes, please let me know and I will answer rapidly. I do not like to make a lot of changes, but…